Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Caspase inhibitor protects against hepatic I/R injury in rat model

April 29, 2002

Peptidomimetic HCV protease inhibitors under study at Lilly

April 25, 2002

New treatments for IBD in early development at Nobex

April 25, 2002

Celltech and Biogen collaborate on CDP-571

April 25, 2002

FDA advisory panel recommends reintroduction of Lotronex for irritable bowel syndrome

April 25, 2002

LY-582563/MCC-478 more active than PMEA against wild-type and mutant HBV

April 25, 2002

Interferon omega safe and effective in HCV-infected patients

April 25, 2002

Promising in vitro anti-HBV activity described for MCC-478 this week at JSGE meeting

April 24, 2002

Patient enrollment completed in phase II trial of interferon omega in chronic hepatitis C

April 22, 2002

Nonabsorbable antibiotics for treatment of gastrointestinal disorders

April 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...